Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Insulin glargine better value than NPH in T2DM

    • 13 Accesses

    This is a preview of subscription content, log in to check access.


    1. 1.

      McEwan P, Mehin N, Tetlow AP, Sharplin P.The relative cost effectiveness of switching to insulin glargine versus NPH insulin in insulin naive and non insulin naive Type 2 diabetes patients using UK real life data. Value in Health 10: A223, No. 6, Nov-Dec 2007

    Download references

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Insulin glargine better value than NPH in T2DM. Pharmacoecon. Outcomes News 541, 8 (2007). https://doi.org/10.2165/00151234-200705410-00010

    Download citation


    • Discrete Event
    • Insulin Glargine
    • Health Utility
    • Discrete Event Simulation
    • Lifetime Cost